🇺🇸 Carbamazepine (Tegretol) in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 2 reports (18.18%)
  2. Anxiety — 1 report (9.09%)
  3. Convulsion — 1 report (9.09%)
  4. Delusion — 1 report (9.09%)
  5. Depressed Mood — 1 report (9.09%)
  6. Dizziness — 1 report (9.09%)
  7. Drug Dose Omission — 1 report (9.09%)
  8. Headache — 1 report (9.09%)
  9. Nausea — 1 report (9.09%)
  10. Renal Pain — 1 report (9.09%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is Carbamazepine (Tegretol) approved in United States?

Carbamazepine (Tegretol) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Carbamazepine (Tegretol) in United States?

Korean Epilepsy Society is the originator. The local marketing authorisation holder may differ — check the official source linked above.